Israel - English - Ministry of Health

propharm ltd - ketamine as hydrochloride - solution for injection / infusion - ketamine as hydrochloride 10 mg/ml - ketamine - * as the sole anaesthetic agent for diagnostic and surgical procedures.when used by intravenous or intramuscular injection, ketamine propharm 10mg/ml is best suited for short procedures. with additional doses, or by intravenous infusion, ketamine propharm 10mg/ml can be used for longer procedures. if skeletal muscle relaxation is desired a muscle relaxant should be used and respiration should be supported.* for the induction of anaesthesia prior to the administration of other general anaesthetic agents.* to supplement other anaesthetic agents.specific areas of application or types of procedure: when the intramuscular route of administration is preferred.* debridement, painful dressings and skin grafting in burned patients as well as other superficial surgical procedures.* neurodiagnostic procedures such as pneumoencephalograms, ventriculograms, myelograms and lumbar punctures.* diagnostic and operative procedures of the eye, ear, nose and mouth including dental extractions.( note: eye movement may persist during ophthalmological procedures).* anaesthesia in poor-risk patients with depression of vital functions or where depression of vital functions must be avoided if at all possible.* orthopaedic procedures such as closed reduction, manipulation femoral pinning, amputations and biopsies.* sigmoidoscopy and minor surgery of the anus and rectum, circumcision and pilonidal sinus. * cardiac catheterization procedures.* caesarian section: as an induction agent in the absence of elevated blood pressure.* anaesthesia in the asthmatic patient, either to minimise the risk of an attack of bronchospasm developing or in the presence of bronchospasm where anaesthesia cannot be delayed.

Ireland - English - HPRA (Health Products Regulatory Authority)

propharma group netherlands b.v. - anhydrous tiotropium bromide - inhalation powder, hard capsule - 18 microgram(s) - tiotropium bromide

Israel - English - Ministry of Health

propharm ltd - ticagrelor - film coated tablets - ticagrelor 60 mg - ticagrelor - ticagrelor propharm is indicated for co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israel - English - Ministry of Health

propharm ltd - ticagrelor - film coated tablets - ticagrelor 90 mg - ticagrelor - ticagrelor propharm is indicated for co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

propharma australia pty. ltd - olaquindox; ground wheat - oral powder, pre-mix - olaquindox antibiotic active 100.0 g/kg; ground wheat food-plant other 0.0 u - nutrition & metabolism - pigs | boar | gilt | piglet | sow | swine - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

Israel - English - Ministry of Health

propharm ltd - oxybutynin hydrochloride - solution for intravesical - oxybutynin hydrochloride 1 mg / 1 ml - oxybutynin - vesoxx is indicated for the suppression of neurogenic detrusor overactivity (ndo) in children from 6 years of age and adults, who are managing bladder emptying by clean intermittent catheterization (cic), if they cannot be adequately managed by oral anticholinergic treatment due to lack of efficacy and/or intolerable side effects..

Israel - English - Ministry of Health

propharm ltd - rivaroxaban - film coated tablets - rivaroxaban 10 mg - rivaroxaban - prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. prevention of recurrent deep vein thrombosis (dvt) and pulmonary embolism (pe), adults (following completion of at least 6 months therapy for dvt or pe).

Israel - English - Ministry of Health

propharm ltd - rivaroxaban - film coated tablets - rivaroxaban 15 mg - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Israel - English - Ministry of Health

propharm ltd - rivaroxaban - film coated tablets - rivaroxaban 20 mg - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Israel - English - Ministry of Health

propharm ltd - atosiban - solution for injection/ concentrate for solution for infusion - atosiban 7.5 mg / 1 ml - atosiban - atosiban altan is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes- a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate